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Abstract
The Panel on Food Additives and Flavourings of the European Food Safety Authority was requested to
deliver a scientific opinion on the implications for human health of the product Grill flavour concentrate
(vegetable) [FL-no: 21.002] in the Flavouring Group Evaluation 501 (FGE.501), according to Regulation
(EC) No 1331/2008 and Regulation (EC) No 1334/2008 of the European Parliament and of the Council.
The product is derived from heat-treated canola oil and intended to be used as a food flavouring with
grilled aroma in a wide variety of food categories. Information on manufacturing and compositional data
was considered adequate to show the reproducibility of the production process. The chronic dietary
exposure to the substance estimated using the added portions exposure technique (APET) was
calculated to be 0.402 and 0.252 mg/person per day for a 60-kg adult and for a 15-kg child, respectively.
Based on exposure estimate and the results from the repeated-dose toxicity studies, a sufficient margin
of safety could be calculated. However, the Panel noted that for six constituents of the flavouring there is
an indication for genotoxicity. Therefore, these six substances have to be further considered. Until these
evaluations have been finalised the safety of Grill flavour concentrate (vegetable) cannot be fully
assessed.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background
The use of flavourings in food is regulated under Regulation (EC) No 1334/20081 of the European
Parliament and Council of 16 December 2008 on flavourings and certain food ingredients with
flavouring properties for use in and on foods. On the basis of article 9(a) of this Regulation, an
evaluation and approval are required for flavouring substances.
Regulation (EC) No 1331/20082 applies for the evaluation and approval of new ‘other’ flavouring.
An application for authorisation as a new ‘other’ flavouring of: Grill flavour concentrate (vegetable)
has been submitted to the Commission.
In order for the Commission to be able to consider its inclusion in the Union list of flavourings and
source materials (Annex of Regulation (EC) No 1334/2008), EFSA should carry out a safety assessment
of this product as a new ‘other’ flavouring.
1.1.2. Terms of reference
The European Commission requests the European Food Safety Authority to carry out a safety
assessment on the product “Grill flavour concentrate (vegetable)” as “other flavouring” in accordance
with Regulation (EC) No 1331/2008 establishing a common authorisation procedure for food additives,
food enzymes and food flavourings.
1.2. Information on existing authorisation and/or evaluations from
other authorities
The Panel is not aware of existing authorisations and/or evaluations of the flavouring ‘Grill flavour
concentrate (vegetable)’ by other authorities.
2. Data and methodologies
2.1. Data
The applicant has submitted a dossier in support of its application for the authorisation of the food
flavouring ‘Grill flavour concentrate (vegetable)’ (see Documentation provided to EFSA n. 5). The
flavouring is intended to be used in meats and meat products, sauces and similar products (ketchups,
BBQ sauces), processed cheese and cream cheese, as well as snacks.
Additional information was sought from the applicant during the assessment process in response to
requests from EFSA sent on 7 April 2016, 25 October 2016, 8 February 2017, 5 October 2017 and 18
September 2018. The applicant provided the requested information (see Documentation provided to
EFSA n. 6; 7; 8; 9 and 10).
2.2. Methodologies
This assessment was conducted in line with the principles described in the EFSA Guidance on
transparency with regard to scientific aspects of risk assessment (EFSA Scientific Committee, 2009)
and following the relevant existing guidance documents from the EFSA Scientific Committee.
The FAF Panel assessed the safety of the ‘Grill flavour concentrate (vegetable)’ as an example of
‘other flavourings’ in line with the principles laid down in Regulation (EC) No 1331/2008, Regulation
(EC) No 1334/2008, as well as the criteria outlined in the current ‘Guidance on the data required for
the risk assessment of flavourings to be used in or on foods’ (EFSA CEF Panel, 2010), Part B. IV.
‘Information to be supplied with an application for the authorisation of Other Flavourings’ (see
Appendix D). In addition, the EFSA Scientific Committee Statement on genotoxicity assessment of
chemical mixtures (EFSA Scientific Committee, 2019) was also considered in this assessment.
1 Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and certain
food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 1601/91,
Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L 354, 31.12.2008, p. 34–50.
2 Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common
authorisation procedure for food additives, food enzymes and food flavourings. OJ L354, 31.12.2008, p. 1–6.
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3. Assessment
3.1. Technical data
3.1.1. Identity of the flavouring
The applicant has provided the following information with respect to the identity of the flavouring.
Chemical name: Not applicable
FL-no: 21.002
CAS Number: Not available
EINECS Number: Not available
Synonyms: Not available
Trade name: The generic name of the flavouring is ‘Grill flavour concentrate (vegetable)’.
According to the applicant, the product is not marketed as such but used only
internally for the manufacturing of flavourings. Therefore, no trade name of
the flavouring exists
Chemical formula: Not applicable (complex mixture of volatiles)
Structural formula: Not applicable
Molecular weight: Not applicable
3.1.2. Specifications
The specifications of ‘Grill flavour concentrate (vegetable)’ are listed in Table 1.
Table 1: Specifications of ‘Grill flavour concentrate (vegetable)’





Grill flavour concentrate (vegetable) is derived from rapeseed oil obtained from
Brassica napus, low in erucic acid (< 2%) subjected to a heating process and subsequent
distillation steps
Composition Distributions (GC peak area percentages)
of the following chemical groups
Alkanes/alkenes (aliphatic saturated and
unsaturated hydrocarbons): 20–25%
Saturated and unsaturated carboxylic acids:
short- and medium-chain (C4–C11) fatty acids
33–34%; long-chain fatty acids 2–4%
Aromatic compounds: 1–2%
Saturated and unsaturated aldehydes and
ketones: 9–10%
Acrolein < 5 mg/kg
Benzo(a)pyrene < 2 lg/kg
Benzo(a)anthracene < 5 lg/kg
Benzo(c)fluorene < 20 lg/kg





Sensory profile Clear, yellow-orange liquid that is oil-soluble. It carries an intensive grill note
Physical
characteristics
Water content < 0.1%
Refractive index 20°C 1.447–1.467
Density 20°C 0.906–0.926
GC: gas chromatography; PAHs: polycyclic aromatic hydrocarbons.
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3.1.3. Manufacturing process
Source material
The source material of the flavouring ‘Grill flavour concentrate (vegetable)’ is canola oil. It is
derived from the seeds of Brassica napus by pressing and solvent extraction, followed by
conventionally employed refining steps, i.e. degumming, neutralisation, bleaching and deodorisation.
According to a certificate provided by the applicant, the specification of the refined canola oil meets
the requirements regarding heavy metals, mycotoxins, dioxins and 3-monochloropropane-1, 2-diol (3-
MCPD) according to Commission Regulation (EC) No 1881/20063 and the requirements regarding
pesticide residues according to Regulation (EC) No 396/20054 of the European Parliament and of the
Council. Analytical data on tocopherols, heavy metals, polycyclic hydrocarbons and dioxins/
polychlorinated biphenyls (PCBs) have been provided for three batches of refined canola oil used as
starting material for the production of the flavouring.
Genetically modified organism
The flavouring does not contain and is not produced from genetically modified organisms (GMOs).
Production process
Refined canola oil is pumped together with air at defined flow rates through a stainless steel tube
heated at high temperature. Formed solid matter is constantly removed by a wiper rotating inside the
tube, and the reaction mixture is passed through water in downstream washing flasks. After combining
the aqueous solutions from the washing flasks, the organic phase is separated and subsequently
subjected to three sequential fractionated distillations under vacuum (see Appendix F).
Technical details of the production process and key parameters have been made available to the
Panel.
3.1.4. Compositional data
The identification of the volatile constituents was based on the analysis of ‘Grill flavour concentrate
(vegetable)’ (batch no. 202509) by gas chromatography and capillary gas chromatography/mass
spectrometry (GC/MS). Under the employed conditions, 630 peaks were detected. Of these, 156
(corresponding to 63% of the total peak area) were identified by comparison of the mass spectral data
to those of authentic reference compounds or commercially available MS libraries; 88 peaks
(corresponding to 21% of the total peak area) were tentatively identified based on fragmentation
patterns of homologous compounds, and 386 peaks (corresponding to 16% of the total peak area)
remained unidentified (Table 2).





% of total peak
area
Relative peak area of single components
Average % of peak
area
Max % of peak
area
All peaks 630 100 0.16 5.4
Identified(a) 156 63 0.39 5.4
Tentatively
identified(b)
88 21 0.22 2.1
Not identified 386 16 0.05 1.1
GC/MS: gas chromatography/mass spectrometry.
(a): By means of MS/Reference library.
(b): Compared with fragmentation pattern of homologous compounds.
3 Regulation (EC) No 1881/2006 of the European Parliament and of the Council of 19 December 2006 setting maximum levels for
certain contaminants in foodstuffs. OJ L 364, 20.12.2006, p. 5–24.
4 Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels
of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. OJ L 70,
16.3.2005, p. 1–16.
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Most of the constituents of the flavouring belong to the chemical classes of saturated and
unsaturated short- and medium-chain (C4–C11) fatty acids (33–34%) and long-chain fatty acids (2–4%).
They are quantitatively followed by aliphatic saturated and unsaturated hydrocarbons (20–25%),
aldehydes/ketones (9–10%) and aromatic compounds (1–2%).
The 20 principal volatile constituents identified in ‘Grill flavour concentrate (vegetable)’ are shown in
Table 3.
Information on the 156 identified and the 88 tentatively identified substances is presented in
Appendix A (Tables A.1, A.2 and A.3). The highest individual percentage peak areas among the fractions
of tentatively identified and unidentified constituents were 2.1% and 1.1%, respectively (Table 2).
To demonstrate batch-to-batch variability, the applicant presented a comparison of the GC-FID (gas
chromatography–flame ionisation detection) chromatograms of five batches (i.e. batch 202509
produced on 18.10.2012; batch 202510 produced on 24.10.2012; batch 202511 produced on
22.11.2012; batch 202512 produced on 27.11.2012; batch 202513 produced on 29.11.2012) of the
‘Grill flavour concentrate (vegetable)’. Despite their complexity, the chromatograms showed high visual
similarity, suggesting a good reproducibility of the manufacturing process. This was supported by
quantitative comparisons of the peak area percentages for more than 630 peaks; the Panel considered
the distributions of the volatiles as sufficiently consistent.
Batch number 202513 was used for toxicological tests.
3.1.5. Stability of the substance, and reaction and fate in food
The stability was tested by monitoring the concentrations of 20 selected constituents (saturated
and unsaturated fatty acids, alkanes/alkenes, aldehydes/ketones and an alkylfuran) upon storage of
the flavouring. The total amount of the analysed constituents decreased by 2.9% after storage for
4 months at room temperature and by 18% after storage of the flavouring for 7 months in the
refrigerator. However, the relative proportions of the 20 analysed representatives of different chemical
classes remained sufficiently consistent, indicating that over this storage period there is no significant
change in the overall composition of the flavouring.
Table 3: The 20 principal identified constituents of ‘Grill flavour concentrate (vegetable)’, expressed
as percentage of total peak area determined by GC/MS in batch no. 202509






















GC/MS: gas chromatography/mass spectrometry.
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No data on reactions and fate of the flavouring in food have been provided by the applicant.
However, taking into account the nature of the constituents, the Panel considered that the flavouring is
not expected to react in food differently from other chemically defined flavourings substances.
3.2. Structural/metabolic similarity to substances present in existing
FGEs (Appendix A)
Some of the identified constituents in the Grill flavour concentrate (79 substances out of 156) have
been already evaluated by EFSA or are currently being evaluated as chemically defined flavouring
substances in one of the Flavouring Group Evaluations (FGE), according to Commission Regulation
(EC) No 1565/20005. Their chemical structures, together with their evaluation status, are shown in
Appendix A (Table A.1). The remaining identified constituents in the Grill flavour concentrate (i.e. 77
substances out of 156) were not evaluated by EFSA. Their structures, shown in Appendix A
(Table A.2), are similar to those of already evaluated chemically defined flavouring substances. The
tentatively identified components are listed in Appendix A (Table A.3).
3.3. Information on existing evaluations from EFSA
Grill flavour concentrate (vegetable) has not been evaluated by EFSA before.
3.4. Exposure assessment
The data necessary for the calculation of exposure estimates (i.e. normal and maximum occurrence
levels for refined subcategories of foods and beverages) are reported in Appendix B.
3.4.1. Chronic dietary exposure
The exposure assessment to be used for the safety evaluation of the flavouring is the chronic added
portions exposure technique (APET) estimate (EFSA, 2010). The chronic APET for [FL-no: 21.002] has
been calculated for adults and children (see Table 4). Based on use levels provided by the applicant (see
Appendix B), the chronic APET calculation is based on the combined normal occurrence level.
Although the flavouring is not intended to be used in food categories specifically intended for
infants and toddlers, these could still be exposed through consumption of foods from the general food
categories, which may contain the flavouring. However, at present, there is no generally accepted
methodology to estimate chronic dietary exposure in these age groups resulting from consumption of
foods from the general categories. Exposure of infants and toddlers is currently under consideration by
EFSA.
3.4.2. Acute dietary exposure
The acute APET calculation for [FL-no: 21.002] is based on the combined maximum occurrence
level and large portion size, i.e. three times standard portion size (see Appendix B).
Table 4: APET – Chronic Dietary Exposure to ‘Grill flavour concentrate (vegetable)’














Adults(e) 6.7 402 0 0 6.7 402
Children(f) 16.8 252 0 0 16.8 252
(a): APET: added portions exposure technique; bw: body weight: the chronic APET calculation is based on the combined normal
occurrence level.
(b): APET Added is calculated on the basis of the normal amount of flavouring added to a specific food category.
(c): APET Other Dietary Sources is calculated based on the natural occurrence of the flavouring in a specified food category.
(d): APET Combined is calculated based on the combined amount of added flavouring and naturally occurring flavouring in a
specified food category.
(e): For the adult APET calculation, a 60-kg person is considered representative.
(f): For the child APET calculation a 3-year-old child with a 15-kg body weight is considered representative.
5 Commission Regulation (EC) No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an
evaluation programme in application of Regulation (EC) No 2232/96 of the European Parliament and of the Council. OJ L 180,
19.7.2000, p. 8–16.
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Although the flavouring is not intended to be used in food categories specifically intended for
infants and toddlers, these could still be exposed through consumption of foods from the general food
categories, which may contain the flavouring. However, at present, there is no generally accepted
methodology to estimate acute dietary exposure in these age groups resulting from consumption of
foods from the general categories. Exposure of infants and toddlers is currently under consideration by
EFSA.
Figures for the chronic APET value for the flavouring are given in Table 5.
3.4.3. Exposure via other sources than from the use of the flavouring
According to the information available to the Panel, Grill flavour concentrate (vegetable) is not
intended to be used for purposes other than food flavouring.
However, there may be exposure to individual constituents of Grill flavour concentrate (vegetable)
via their use as chemically defined flavouring substances.
In addition, several of the constituents of the flavouring are also formed via thermo-oxidation of
fatty acids (see Table 3 in Section 3.1.4) and thus humans are exposed to these constituents via
consumption of heated lipid-containing foods.
3.5. Biological and toxicological data
3.5.1. Genotoxicity
Grill flavour concentrate (vegetable) is a complex mixture containing approximately 63% as
identified components, 21% as tentatively identified components and 16% as unidentified components
expressed as relative peak areas.
The recommended approach by the EFSA Scientific Committee (2019) for the genotoxicity
assessment of mixtures containing a substantial fraction of unidentified components, foresees that first
the genotoxicity of the chemically identified components of the mixture should be assessed individually,
using all available information, including read across and QSAR considerations about their potential
genotoxicity. The Panel noted that the dossier has been submitted before publication of the EFSA
Scientific Committee statement (EFSA, Scientific Committee, 2019), but decided to apply the approach
as described in this statement to the compositional data provided by the applicant.
To this end, the identified constituents of the ‘Grill flavour concentrate (vegetable)’ (see Appendix A –
Tables A.1 and A.2) were evaluated individually both in silico and for 79 components, which were already
assessed by EFSA as flavouring substances, also via genotoxicity data made available by industry (see
Appendix A – Table A.1). Concerning the in silico analysis, the OECD QSAR toolbox (version 4.2) was
used for all identified constituents in order to identify structural alerts related to genotoxicity and to
derive predictions for specific genotoxicity testing (i.e. Ames test, in vitro chromosomal aberration and
micronucleus tests profilers). Structural alerts (alpha-beta unsaturated carbonyls and simple aldehyde)
were identified in 23 substances.
For 17 of these substances, the genotoxicity concern identified via the in silico analysis was ruled
out for by the experimental data submitted by industry and assessed by the CEF Panel and by FAF
Panel in the context of genotoxicity evaluation of flavourings (EFSA CEF Panel, 2015, 2016, 2018;
EFSA FAF Panel, 2018; see Appendix A – Table A.1).
Table 5: APET – Acute Dietary Exposure to ‘Grill flavour concentrate (vegetable)’














Adults(e) 50 3,000 0 0 50 3,000
Children(f) 126 1,890 0 0 126 1,890
(a): APET: added portions exposure technique; bw: body weight: the acute APET calculation is based on the combined
maximum occurrence level.
(b): APET Added is calculated on the basis of the maximum amount of flavouring added to a specific food category.
(c): APET Other Dietary Sources is calculated based on the natural occurrence of the flavouring in a specified food category.
(d): APET Combined is calculated based on the combined amount of added flavouring and naturally occurring flavouring in a
specified food category.
(e): For the adult APET calculation, a 60-kg person is considered representative.
(f): For the child APET calculation, a 3-year-old child with a 15-kg body weight is considered representative.
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For four substances (i.e. 2-cyclohexen-1-one, 10-oxodecanoic acid, 9-oxononanoic acid and
pentadecanal), the Panel noted that structurally related flavouring substances exist in other FGEs for
which no safety concerns were identified (see Appendix A – Table A.2). Cyclohexen-1-one has structural
similarity to flavouring substances methylcyclohex-2-en-1-one [FL-no: 07.098] and methyl-2-
cyclopenten-1-one [FL-no: 07.112]) for which the concern on genotoxicity was ruled out in FGE.212Rev1
(EFSA CEF Panel, 2011a) and in FGE.212Rev3 (EFSA CEF Panel, 2015), respectively. The three
aldehydes, 10-oxodecanoic acid, 9-oxononanoic acid and pentadecanal, are structurally similar to a
number of linear saturated aldehydes of comparable chain length (i.e. octanal [FL-no: 05.009], nonanal
[FL-no: 05.025], undecanal [FL-no: 05.034] and dodecanal [FL-no: 05.011]), which are released as
hydrolysis products from several acetal flavouring substances evaluated by EFSA in FGE.03Rev2 (EFSA
CEF Panel, 2011d) and as flavouring substances as such by JECFA in 1999 (JECFA, 1999).
For the remaining two identified components, i.e. 2-decen-1,4-lactone and 2-undecen-4-one, the
Panel noted that the evaluation of their genotoxic potential is still pending in other FGEs, as additional
genotoxicity data have been requested for 2-decen-1,4-lactone in FGE.217Rev2 (EFSA FAF Panel,
2019) (see Appendix A – Table A.1) and for flavouring substances structurally related to 2-undecen-4-
one (i.e. non-2-en-4-one [FL-no: 07.187], oct-2-en-4-one [FL-no: 07.082] and hept-2-en-4-one [FL-no:
07.104]) in FGE.204 (EFSA CEF Panel, 2012) (see Appendix A – Table A.2).
In addition, although no structural alerts for genotoxicity were identified by the OECD QSAR
Toolbox (version 4.2), the Panel identified a potential genotoxicity concern also for four other identified
components of the Grill flavour concentrate (vegetable), i.e. 2-pentylfuran, 2-heptylfuran, 2-octylfuran
and 2-hexylfuran (see Appendix A – Table A.1). This is based on the fact that for three of these four
components (2-pentylfuran [FL-no: 13.059], 2-heptylfuran [FL-no: 13.069], 2-octylfuran [FL-no:
13.162]) additional genotoxicity data were required by the CEF Panel in FGE.67Rev1 (EFSA CEF Panel,
2011b) and FGE.13Rev2 (EFSA CEF Panel, 2011c), respectively. These data are under evaluation in
FGE.67Rev3 and FGE.13Rev3 and are also relevant for the structurally related substance 2-hexylfuran,
which is not under assessment as flavouring substance.
With respect to the tentatively identified constituents, the Panel noted that some of them show
structural similarity with the identified substances (see Appendix A – Table A.3). However, in the
absence of fully confirmatory chemical data, the Panel considered the tentatively identified part of the
mixture as uncharacterised.
Regarding the unidentified fraction of the mixture, the EFSA Scientific Committee recommends as
first option to test it for genotoxicity separately from the rest of the mixture. Alternatively, if this is not
feasible, the testing of the whole mixture should be undertaken (EFSA Scientific Committee, 2019). In
the case of Grill flavour concentrate (vegetable), the Panel considered that the separation and testing
of the unidentified and/or of the tentatively identified part of the mixture would not be technically
feasible. Therefore, the Panel considered not only the available information on individual constituents
of the chemically characterised fraction, but also the experimental data on the whole mixture for the
genotoxicity assessment of the flavouring.
Bacterial reverse mutation assay
In order to investigate the potential of ‘Grill Flavour Concentrate (vegetable)’ and/or its metabolites to
induce gene mutations in bacteria, an Ames test was performed according to OECD Test Guideline 471
(OECD, 1997) and following Good Laboratory Practice (GLP) in five strains of Salmonella Typhimurium
(TA97a, TA98, TA100, TA1535 and TA102) both in the presence and absence of metabolic activation
(Silesia Gerhard Hanke GmbH & Co. KG, 2013). Two separate experiments were performed applying the
plate incorporation method (experiment 1) and the pre-incubation assay (experiment 2). The test article
was evaluated in experiment 1 at five concentrations (ranging from 50 to 5,000 lg/plate), and in
experiment 2 at seven concentrations (ranging from 79 to 5,000 lg/plate) with and without S9-mix.
Appropriate positive controls and ethanol as a vehicle control were evaluated concurrently; all test and
control articles were evaluated in quadruplicate plates. All positive controls induced significant increases
in revertant colony numbers. The test was considered to fulfil the acceptability criteria.
No precipitate was observed at any tested concentration in any tester strain with or without S9-mix.
Toxicity, as evident by the absence or reduction in the mean number of revertant colonies and absence
or reduction in the background bacterial lawn, was observed in experiment 2 at the two highest
concentrations (2,500 and 5,000 lg/plate) in all tester strains with and without S9-mix. No increase in
the mean number of revertant colonies was observed at any tested concentration in any tester strains
with or without S9-mix. No mutagenic activity could be observed under the conditions employed in this
study.
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In vitro micronucleus assay
An in vitro micronucleus assay was carried out according to OECD Test Guideline 487 (OECD, 2010)
and following GLP (Silesia Gerhard Hanke GmbH & Co. KG, 2014). Whole blood cultures were prepared
from healthy donors and peripheral lymphocytes stimulated with phytohaemagglutinin. Based on a
preliminary cytotoxicity range-finder experiment, three doses were selected for two independent
experiments (from 0.05 to 0.25 lL/mL without S9-mix and from 0.05 to 0.40 lL/mL with S9-mix).
Ethanol was used as a vehicle control; mitomycin C (MMC) and cyclophosphamide (CPA) were
employed as positive controls in the absence and presence of S9-mix, respectively. Positive controls
induced significant increases of micronuclei (MN) and the system was considered sensitive and valid.
Cells were treated with the test article after 71 h of culture following two treatment schedules: a short
treatment followed by a recovery period (4 + 18 h) both in the presence and absence of metabolic
activation, and a continuous treatment for 19 h in the absence of metabolic activation. Cells were
harvested about 90 h after culture initiation. Two thousand cells were scored per concentration.
Thirty-four per cent cytotoxicity was observed at the highest concentration after short treatment
with and without S9 mix; 40% cytotoxicity was detected at the highest concentration after continuous
treatment without S9-mix. No statistically significant increase in the frequency of MN was observed at
any concentration analysed. It was concluded that the test article did not induce MN in cultured
human peripheral blood lymphocytes under the experimental conditions employed in this study.
The studies are summarised in Table C.1 in Appendix C.
In vivo studies
No data provided.
3.5.2. Conclusion on genotoxicity
Except for six substances (i.e. 2-decen-1,4-lactone, 2-undecen-4-one, 2-pentylfuran, 2-heptylfuran,
2-octylfuran and 2-hexylfuran), the assessment of individual components did not raise a concern for
genotoxicity.
In addition, the available experimental data obtained with the whole mixture (Grill flavour
concentrate (vegetable), as such) do not indicate a concern for genotoxicity.
Five of the six substances that raised concern regarding genotoxicity (i.e. 2-decen-1,4-lactone, 2-
undecen-4-one, 2-pentylfuran, 2-heptylfuran and 2-octylfuran) are currently under consideration in
other FGEs (i.e. FGEs 217Rev2, 204Rev1, 67Rev3 and 13Rev3). The remaining substance (i.e. 2-
hexylfuran), which is not listed in the Union list of chemically defined flavouring substances,1 can be
covered by the evaluation of the other three 2-alkylfurans.
3.5.3. Absorption, distribution, metabolism and excretion
No information was provided by the applicant on absorption, distribution, metabolism and excretion
(ADME) for Grill flavour concentrate.
3.5.4. Acute toxicity
No information was provided by the applicant on acute toxicity for Grill flavour concentrate.
3.5.5. Short-term and subchronic toxicity
Initially, a 28-day repeated-dose toxicity study and a 90-day subchronic toxicity study were
conducted by the applicant, in order to identify suitable doses and to test the safety of the Grill flavour
concentrate, respectively. To clarify issues raised by the Working group regarding the findings in the
90-day study, the applicant submitted additional toxicity studies; a 14-day dose-range finding (DRF)
study and a 28-day repeated-dose toxicity study. All toxicity studies are described below.
3.5.5.1. 28-Day repeated-dose toxicity study in rats (vivo Science GmbH, 2016)
In order to test the palatability of the doses intended for the 90-day repeated-dose toxicity study, a
non-GLP 28-day DRF study was performed in Wistar rats. There were four treatment groups, each
consisting of six animals each (three males and three females). The control group (0 mg) received
basal diet. The Grill flavour concentrate was administered in the feed at doses of 667, 133, 27 and
0 mg/kg of the feed. An estimated food consumption of 90.0 g/kg body weight (bw) per day equals to
60, 12, 2.4 and 0 mg of the test item per kg/bw per day.
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However, the actual food consumption was 22% and 30% less than anticipated for female and
male rats, respectively, also in the control animals. This resulted in exposures of approximately 47, 9
and 2 mg/kg bw per day for females and 43, 8 and 2 mg/kg bw per day for males over the study
period.
There was no difference among animals of any treatment group regarding general clinical signs and
motor activity. Body weight gain was within normal range in all treatment groups. The mean food and
water consumption of the animals of both sexes was comparable over the duration of the study
among all treatment groups. However, there were some differences in water consumption, which was
higher in the medium-dose females during the whole study period and for the high-dose animals of
both sexes in the beginning of the study. At sacrifice, no difference among the treatment groups were
observed during gross examination.
The 28-day study is shown in table format in Appendix C.
3.5.5.2. 90-Day subchronic study (vivo Science GmbH, 2016)
In a 90-day study conducted in compliance with OECD test Guideline 408, (OECD, 1998) and
according to GLP, 7- to 8-week-old Wistar Han rats (females were nulliparous and non-pregnant) were
grouped in batches of 10 rats/sex per treatment group (randomised by body weight) and were given
dietary exposure either to vehicle (mazola corn oil) or to 72, 14.4 and 2.9 mg of Grill flavour
concentrate (vegetable)/kg bw per day for 92 days. The Panel noted that the actual food consumption
over the study period of 92 days resulted in an exposure that was between 90.8% and 105.5% of the
intended exposure. This resulted in a mean exposure of 73.4, 14.5 and 2.9 mg/kg bw per day for
females and 71.0, 14.1 and 3.0 for males.
The 90-day study is shown in table format in Appendix C.
No animals died or demonstrated adverse clinical symptoms during the study. Significantly
increased body weights (males: day 1; females: days 1–15 were transitory and not dose dependent
while food intake and water consumption declined across the study period in all groups and both
sexes. One male in the high-dose group also had a renal tumour. No organ weights were significantly
altered in treatment groups. No histological abnormalities were reported in the high-dose groups.
A statistically significant increase in plasma creatinine was observed in male rats in the high-
(72 mg/kg bw per day) and medium-dose (14.4 mg/kg bw per day) groups compared to the control.
The effect was dose-related and associated with a statistically significant increase in blood urea at the
top-dose only. The increase in creatinine and urea was not associated with any histological change in
the kidney and in the muscles, though the increase in creatinine was higher than the corresponding
historical control data for this strain of rats.
Additional changes in biochemical plasma parameters were observed at the top dose (i.e. increase
in Cl, Na and Ca and increase in albumin, globulin and total protein), but a correlation with the
increase in creatinine and urea could not be established. Similar to male rats, female rats had an
increase in globulin and total protein and a decrease in albumin/globulin (A/G) ratio at the top dose.
The creatinine level in urine was not measured.
The Panel decided that the observed change in creatinine levels raised a concern for the following
reasons: dose-related, statistically significant, outside the historical control range, correlated with an
increase in plasma urea (additional marker of renal toxicity) and associated with additional changes in
biochemical parameters which were observed at the top dose.
An increase in fatty tissue was observed in both male and female rats. The effect was not dose-
related, was not associated with any histological change in any organ and was not associated with an
increase in body weight and food consumption. The absence of any correlate, in particular, the
absence of any specific organ infiltration by fat tissue, is suggesting that this effect was not adverse;
though a relationship with a metabolic imbalance, if any, cannot be excluded as plasma triglycerides
were not measured in the study.
The Panel noted that the top dose (i.e. 72 mg/kg bw per day) in the 90-day study was not
representing a maximum tolerated dose (MTD) and for this reason a clear correlation with target
organ toxicity could not be ruled out as it is possible that at this dose the effect observed indicated a
target organ toxicity in the kidney.
In response to the request of the Panel to clarify the toxicological significance of the kidney toxicity
observed in the 90-day study, the applicant conducted a 28-day oral toxicity study in rats (see
Section 3.5.5.4) preceded by an appropriate 14-day DRF study. The objective of the DRF study was to
determine the toxicity of the Grill flavour concentrate (vegetable), following daily oral administration to
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the rat for 14 days and to provide the basis for the selection of dose levels up to 350 mg/kg feed, as
requested by the Panel, for a subsequent 28-day study.
3.5.5.3. 14-Day dose-range finding study in rats (Covance, 2018)
The report and detailed description of the DRF study was provided by the applicant. This was
conducted by Covance, under GLP quality assurance.
Seven- to eight-week-old male and female Crl:WI(Han) rats were grouped into two groups of 10
animals each (5 males/5 females). The control group received diet supplemented with corn oil,
whereas the treatment group were given the same diet supplemented with corn oil and the test
substance, at a dose to reach the target dose level of 350 mg/kg bw per day.
No mortality occurred, and no extensive test article-related clinical observations were noted. Body
weight, body weight gain and food consumption were not adversely affected. Organ weights and
organ weights relative to body weights were not significantly altered in the test substance exposed
groups (changes < 10%). The incidence of macroscopic and microscopic abnormalities noted did not
show any significant relationship to treatment, except for a substance-related increase severity in
hyaline droplets, which ranged from minimal in controls to slight/moderate severity grades in males
exposed to 350 mg/kg bw per day. No evidence of cell damage was detected. These findings indicate
that the dose level of 350 mg of the test substance [FL-no. 21.002]/kg bw per day via dietary (oral
intake) is tolerated in rats and a 28-day study could be performed at this dose level.
The 14-day study is shown in table format in Appendix C.
3.5.5.4. 28-Day repeated-dose toxicity study in rats (Covance, 2018)
In a 28-day study conducted in compliance with OECD test Guideline 407 (OECD, 2008) and
according to GLP, nine- to 10-week-old Crl:WI(Han) rats were randomised to treatment groups (5
males and 5 females in each group except ‘second maximum dose group’ for which 2 males and 2
females were included) and provided with ad libitum access to water and feed. The vehicle was corn
oil and animals were administered either vehicle only (controls) or test substance in corn oil by oral
gavage for 28 days. Five principal treatment groups were included, with dose levels of the test
substance at 0, 2.9, 14.4, 72 and 350 mg of the test substance (FL-no. 21.002)/kg bw per day. Two
secondary groups (controls and maximum dose) were used for recovery testing, with treatment
stopping at the end of week 4, allowing 2 weeks recovery prior to necropsy (n = 5/sex per group for
all groups, except n = 2 for a second maximum dose group).
Target concentrations of the test substance in corn oil were achieved. Detailed observations of
weight, clinical observations, functional observational battery and motor activity were made, blood and
over-night urine were collected for detailed analyses (including measurement of kidney damage
indicators) in week 4.
No incidences of mortality and no effects on body weight (apart from a significant, 8%, increase in
terminal body weights of recovery phase females at the highest dose level) or body weight gain or
food consumption were reported in dosing or recovery groups.
A few functional or observational parameters were significantly affected by treatment but none of
these showed a dose dependency (e.g. significantly increased foot splaying in females at 14.4 mg/kg
bw per day).
Exposure to 350 mg/kg bw per day increased absolute and relative kidney weight for both male
and female rats (i.e. 20% and 14% increase in relative kidney weight, respectively) compared to
controls. Recovery testing showed that the increase in kidney weight was partly and fully reversible in
male and female rats, respectively.
A substance-related and dose-dependent increase in albumin:creatinine ratio was observed in male
rats administered 72 and 350 mg/kg bw per day. There was an increase for urine kidney injury
marker-1 (KIM-1): creatinine ratios in male rats administered 350 mg/kg bw per day compared to
controls. Enlarged kidneys were recorded for males administered 350 mg/kg bw per day and pale and/
or mottled kidneys for males exposed to 72 and 350 mg/kg bw per day upon macroscopic
examination. Lower urine volumes were recorded on day 28 for male rats administered 2.9, 72 or
350 mg/kg bw per day. In addition, male rats administered 350 mg/kg bw per day had a small
increase in total plasma protein, which were attributed to a slightly higher increase in globulin and
urea. No other substance-related haematological/clinical biochemical changes were observed.
No treatment-related changes in the amounts of adipose tissue were reported. In addition, no
increase in plasma triglyceride levels was observed for any of the dose groups.
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Males exposed to 72 or 350 mg/kg bw per day showed increased severity of hyaline droplets and
tubular basophilia. In addition, males exposed to the top dose, had an increase in hyaline/granular
casts. Immunohistochemical staining indicated the presence of a2-microglobulin. The Panel notes that
the identification of a2-microglobulin only was performed for controls and the top dose. In addition,
some positive staining of a2-microglobulin was detected in kidney of female rats, which indicates
cross-reaction, and the level of this cross-reactivity compared to the level in male kidney has not been
described.
The applicant argues that formation of hyaline droplets and the concurrent kidney damage is due
to the naturally occurring a2u-globulin and that the substance-related effects on kidney is therefore
not relevant for humans. Despite the limitations pointed out concerning the immunohistochemistry, the
Panel concurs with the view of the applicant that the findings in kidney of male rats are not relevant
for human risk assessment. However, a kidney effect (increase in relative and absolute kidney weight)
was also observed in female rats at the top dose and this was reversible.
Overall, the additional 28-day study with the increased dose level of 350 mg of the test substance
[FL-no: 21.002]/kg bw per day confirms a2u-globulin accumulation indicating potential kidney
pathology in male rats.
The 28-day study is shown in table format in Appendix C.
3.5.6. Chronic toxicity and carcinogenicity
Chronic toxicity/carcinogenicity studies are not available for the safety evaluation of the Grill flavour
concentrate (vegetable).
3.5.7. Reproductive and developmental toxicity
Developmental toxicity studies are not available for the safety evaluation of the Grill flavour
concentrate (vegetable).
3.5.8. Conclusion on toxicity
In the absence of the data falling under Sections 3.5.6 and 3.5.7, the general toxicity of the Grill
flavour concentrate (vegetable) will be based on the available subchronic oral toxicity studies.
From the additional 28-day study, the Panel concluded that the changes in the male kidney are
caused by the a2-microglobulin accumulation, resulting in hyaline droplets formation and hyaline casts
in the kidney. This mechanism is irrelevant for humans (Hard et al., 1993; Swenberg, 1993), and
therefore, the renal changes in the male kidneys in the 90-day study are not further considered.
Similarly, the absence of changes in serum triglycerides levels in the 28-day study indicates that
Grill flavour concentrate (vegetable) [FL-no: 21.002] does not cause metabolic imbalance, thus the
increase in the amount of adipose tissue in the 90-day study is not considered adverse.
On the other hand, in the 90-day study, the Panel noted that Grill flavour concentrate (vegetable)
[FL-no: 21.002] induced statistically significant changes in serum plasma globulin, A/G ratio and total
protein also in female animals. The Panel considered that these effects were adverse. Benchmark dose
(BMD) analyses were applied for these effects in rats and the lower 95% confidence limit (single
sided) of the benchmark dose for a 5% effect (BMDL05) were calculated to be 12.8 to 76.7 mg/kg bw
per day. The BMDL05 was calculated in accordance to the update on the use of the BMD approach
(EFSA Scientific Committee, 2017) using the EFSA web-tool (Appendix E). The models used in the
analysis were consistent and passed statistical validation.
The Panel decided that the BMDL05 value of 12.8 mg/kg bw per day for the parameter A/G ratio
was the most appropriate departure point for the calculation of margin of safety.
3.6. Discussion
Grill flavour concentrate (vegetable) is a complex mixture resulting from the heating of canola oil
and subsequent distillation steps. It contains approximately 63% of identified components, 21% of
tentatively identified components and 16% of unidentified components expressed as relative peak
areas (GC–MS).
Out of 156 identified constituents in the Grill flavour concentrate, 79 have been already evaluated
by EFSA or are currently being evaluated as chemically defined flavouring substances in one of the
FGE. Their chemical structures, together with their evaluation status, are shown in Appendix A
(Table A.1).
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Except for six substances (i.e. 2-decen-1,4-lactone, 2-undecen-4-one, 2-pentylfuran, 2-heptylfuran,
2-octylfuran and 2-hexylfuran), the assessment of individual components did not raise a concern for
genotoxicity. Additional data have been requested to finalise the evaluation of the genotoxic potential
of these six substances. The available experimental data obtained with the whole mixture (Grill flavour
concentrate (vegetable) as such) do not indicate a concern for genotoxicity.
The chronic dietary exposure to the substance estimated using the APET was calculated to be
0.402 mg/person per day for a 60-kg adult and 0.252 mg/person per day for a 15-kg child.
Based on the BMDL05 value of 12.8 mg/kg bw per day for the parameter A/G ratio and the
exposure estimate mentioned above, the Panel calculated margins of safety of 1,910 for adults and
762 for children (see Table 6).
The Panel considers these margins of safety calculated for Grill flavour concentrate (vegetable) [FL-
no: 21.002] as sufficient.
4. Conclusions
Based on exposure estimate and the results from the repeated-dose toxicity studies, sufficient
margins of safety could be calculated.
However, the Panel noted that for six constituents of the flavouring (i.e. 2-decen-1,4-lactone,
2-undecen-4-one, 2-pentylfuran, 2-heptylfuran, 2-octylfuran and 2-hexylfuran) there is an indication
for genotoxicity. Therefore, these six substances have to be evaluated. Until these evaluations have
been finalised in the context of FGE.217, FGE.204, FGE.67 and FGE.13, the safety of Grill flavour
concentrate (vegetable) cannot be fully assessed.
5. Recommendations
The Panel recommends that on receipt of genotoxicity data, that will cover the six constituents for
which there is an indication for genotoxicity, this opinion should then be reconsidered.
Documentation provided to EFSA
1) Covance, 2018. Grill flavour concentrate (vegetable): 28 Day Oral (Gavage) Administration
Toxicity Study in the Rat Followed by a 2 Week Recovery Period. Covance Study Number
8384830, December 2018. Unpublished study report submitted by Silesia Gerhard Hanke
GmbH & Co. KG.
2) Covance, 2018. Grill flavour concentrate (vegetable): 14 Day Range-finding Study in the Rat.
Covance Study Number 8384829, July 2018. Unpublished study report submitted by Silesia
Gerhard Hanke GmbH & Co. KG.
3) Silesia Gerhard Hanke GmbH & Co. KG, 2013. Test report: Ames test Determination of the
mutagenic potential of Grill Flavour Concentrate (vegetable) Material number: 33500103 with
the Bacterial Reverse Mutation Test. Study number 13071001G803, October 2013.
Unpublished study report submitted by Silesia Gerhard Hanke GmbH & Co. KG.
4) Silesia Gerhard Hanke GmbH & Co. KG, 2014. Test report: Micronucleus test Determination
of the genotoxic potential of Grill Flavour Concentrate (vegetable) Material number:
33500103 with the In Vitro Mammalian Micronucleus Test in Human Lymphocytes. Study
number 13071001G860, January 2014. Unpublished study report submitted by Silesia
Gerhard Hanke GmbH & Co. KG.
5) Silesia Gerhard Hanke GmbH & Co. KG, Oct 2015. Application for authorisation of Grill flavour
concentrate (vegetable) in accordance with Regulation (EC) No 1331/2008 according to the
Regulation (EC) No 1334/2008. Submitted by Silesia Gerhard Hanke GmbH and Co. KG.






lg/kg bw per day
(mg/kg bw per day)
Margin of
Safety
Adults 90-Day feeding study in rats on Grill flavour
concentrate (vegetable) [Fl-no:12.002]
12.8 6.7 (0.0067) 1,910
Children 16.8 (0.0168) 762
BMDL05: benchmark dose for a 5% effect; APET: added portions exposure technique; bw: body weight.
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6) Silesia Gerhard Hanke GmbH and Co. KG, May 2016. Responses to the request for additional
information on the product Grill flavour concentrate (vegetable) [FL-no: 21.002], (EFSA-Q-
2015-00821). Submitted by Silesia Gerhard Hanke GmbH and Co. KG on 31/5/2016 in reply
to EFSA letter dated 7/4/2016.
7) Silesia Gerhard Hanke GmbH and Co. KG, Jan 2017. Responses to the request for additional
information on the product Grill flavour concentrate (vegetable) [FL-no: 21.002], (EFSA-Q-
2015-00821). Submitted by Silesia Gerhard Hanke GmbH and Co. KG on 9/1/2017 in reply to
EFSA letter dated 25/10/2016.
8) Silesia Gerhard Hanke GmbH and Co. KG, May 2017. Responses to the request for additional
information on the product Grill flavour concentrate (vegetable) [FL-no: 21.002], (EFSA-Q-
2015-00821). Unpublished data submitted by Silesia Gerhard Hanke GmbH and Co. KG on
30/05/2017 in reply to EFSA letter dated 8/2/2017.
9) Silesia Gerhard Hanke GmbH and Co. KG, Aug 2018. Responses to the request for additional
information on the product Grill flavour concentrate (vegetable) [FL-no: 21.002], (EFSA-Q-2015-
00821). Submitted by Silesia Gerhard Hanke GmbH and Co. KG on 3/8/2018 in reply to EFSA
letter dated 05/10/2017, which was followed by a clarification teleconference on 13/7/2018.
10) Silesia Gerhard Hanke GmbH and Co. KG, Dec 2018. Responses to the request for additional
information on the product Grill flavour concentrate (vegetable) [FL-no: 21.002], (EFSA-Q-
2015-00821). Submitted by Silesia Gerhard Hanke GmbH and Co. KG on 10/12/2018 in reply
to EFSA letter dated 18/9/2018.
11) Vivo Science GmbH, 2015. Dose range finding study in Wistar rats (28d) with Grill flavour
concentrate. Summary Report L09-030 DRF. Study number L09-030 DRF, May 2015.
Unpublished study report submitted by Silesia Gerhard Hanke GmbH and Co. KG.
12) Vivo Science GmbH, 2016. Repeated dose toxicity study of Grill flavour concentrate. Study
number L09-030, July 2016. Unpublished study report submitted by Silesia Gerhard Hanke
GmbH and Co. KG.
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ADME absorption, distribution, metabolism and excretion
A/G albumin and globulin
APET added portions exposure technique
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CAS Chemical Abstract Service
CEF Panel on Scientific Panel on Food Contact Materials, Enzymes, Flavourings and
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EINECS European Inventory of Existing Commercial chemical Substances
FAF EFSA Panel on Food Additives and Flavourings
FAO Food and Agriculture Organization of the United Nations
FGE Flavouring Group Evaluation
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FLAVIS (FL) Flavour Information System
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GLP good laboratory practice
GMO genetically modified organisms
JECFA The Joint FAO/WHO Expert Committee on Food Additives




MSDI maximised survey-derived daily intake
MTD maximum tolerated dose
NOAEL no observed adverse effect level
OECD Organisation for Economic Co-operation and Development
PAHs polycyclic aromatic hydrocarbons
PCB polychlorinated biphenyl
QSAR quantitative structure–activity relationship
SPET single portion exposure technique
WHO World Health Organization
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112-40-3 Dodecane 0.12 Class I No safety concern at the
estimated level of intake









629-62-9 Pentadecane 0.71 Class I No safety concern at the
estimated level of intake




629-59-4 Tetradecane 0.11 Class I No safety concern at the
estimated level of intake




21964-44-3 Non-1-en-3-ol 0.03 Class II 1.2.2 No safety concern at the
estimated level of intake




108-39-4 3-Methylphenol OH 0.14 Class I No safety concern at the
estimated level of intake




95-48-7 2-Methylphenol OH 0.02 Class I No safety concern at the
estimated level of intake
based on the MSDI
approach
Appendix A – Constituents of Grill concentrate
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0.09 Class I No safety concern at the
estimated level of intake




108-95-2 Phenol OH 0.13 Class I No safety concern at the
estimated level of intake




644-35-9 2-Propylphenol OH 0.12 Class I No safety concern at the
estimated level of intake




90-00-6 2-Ethylphenol OH 0.12 Class I No safety concern at the
estimated level of intake




66-25-1 Hexanal 0.005 Class I (d) No safety concern at the
estimated level of intake








124-13-0 Octanal 0.29 Class I (d) No safety concern at the
estimated level of intake






Flavouring Group Evaluation 501





















100-52-7 Benzaldehyde 0.03 Class I (d) No safety concern at the
estimated level of intake




124-19-6 Nonanal 1.16 Class I (d) No safety concern at the
estimated level of intake








104-87-0 p-Tolualdehyde O 0.006 Class I (d) No safety concern at the
estimated level of intake




111-71-7 Heptanal 0.09 Class I (d) No safety concern at the
estimated level of intake

































O 1.15 1.1.1 (c) No safety concerns for
genotoxicity
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3913-81-3 trans-2-Decenal or (E)-
2-Decenal








110-43-0 Heptan-2-one 0.03 Class II No safety concern at the
estimated level of intake








106-35-4 Heptan-3-one O 0.005 Class II No safety concern at the
estimated level of intake








112-12-9 Undecan-2-one O 0.36 Class II No safety concern at the
estimated level of intake
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111-13-7 Octan-2-one 0.13 Class II No safety concern at the
estimated level of intake








821-55-6 Nonan-2-one 0.24 Class II No safety concern at the
estimated level of intake








106-68-3 Octan-3-one 0.02 Class II No safety concern at the
estimated level of intake










O 0.12 Class II 2.6 (c) No safety concern at the
estimated level of intake






O 0.10 Class II 2.6 (c) No safety concern at the
estimated level of intake
based on the MSDI
approach
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925-78-0 Nonan-3-one O 0.03 Class II No safety concern at the
estimated level of intake








2345-28-0 Pentadecan-2-one O 0.13 (5-Pentyldihydrofuran-
2-(3H)-one +Pentadecan-2-
one)(e)
Class II No safety concern at the
estimated level of intake








693-54-9 Decan-2-one 0.45 Class II No safety concern at the
estimated level of intake




6175-49-1 Dodecan-2-one O 0.19 Class II No safety concern at the
estimated level of intake




1629-60-3 Hex-1-en-3-one O 0.005 (Hexanal + Hex-1-en-
3-one)(e)
Class II 1.2.2 (c) No safety concern at the
estimated level of intake




4485-09-0 Nonan-4-one O 0.04 Class II No safety concern at the
estimated level of intake
based on the MSDI
approach.
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107-92-6 Butyric acid 0.40 Class I No safety concern at the
estimated level of intake








109-52-4 Valeric acid or Pentanoic
acid
0.8 Class I No safety concern at the
estimated level of intake








91-57-6 Hexanoic acid 2.45 Class I No safety concern at the
estimated level of intake








124-07-2 Octanoic acid 5.38 Class I No safety concern at the
estimated level of intake
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334-48-5 Decanoic acid 4.96 Class I No safety concern at the
estimated level of intake










O 0.33 Class I No safety concern at the
estimated level of intake










O 0.66 Class I No safety concern at the
estimated level of intake










O 0.74 Class I No safety concern at the
estimated level of intake
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O 0.04 Class I No safety concern at the
estimated level of intake










O 0.22 Class I No safety concern at the
estimated level of intake










O 0.14 Class I No safety concern at the
estimated level of intake




111-14-8 Heptanoic acid 3.93 Class I No safety concern at the
estimated level of intake
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112-05-0 Nonanoic acid 2.62 Class I No safety concern at the
estimated level of intake








112-38-9 Undec-10-enoic acid or
10-Undecenoic acid OH
O 0.74 Class I No safety concern at the
estimated level of intake






0.04 Class I No safety concern at the
estimated level of intake








112-37-8 Undecanoic acid OH
O
0.65 Class I No safety concern at the
estimated level of intake
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591-80-0 Pent-4-enoic acid or 4-
Pentenoic acid OH
O 0.73 Class I No safety concern at the
estimated level of intake








14436-32-9 Dec-9-enoic acid or 9-
Decenoic acid OH
O 0.79 Class I No safety concern at the
estimated level of intake















0.02 Class I No safety concern at the
estimated level of intake












0.06 Class I No safety concern at the
estimated level of intake








0.27 Class I No safety concern at the
estimated level of intake
based on the MSDI
approach
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10352-88-2 trans-2-Heptenoic acid 0.23 Class I No safety concern at the
estimated level of intake











4230-97-1 Allyl octanoate O
O




123-68-2 Allyl hexanoate O
O






O 0.04 Class I No safety concern at the
estimated level of intake
based on the MSDI
approach









0.15 Class I No safety concern at the
estimated level of intake










104-61-0 Nonano-1,4-lactone 0.12 Class I No safety concern at the
estimated level of intake




108-29-2 Pentano-1,4-lactone 0.06 Class I No safety concern at the
estimated level of intake
based on the MSDI
approach
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105-21-5 Heptano-1,4-lactone O O 0.12 Class I No safety concern at the
estimated level of intake




695-06-7 Hexano-1,4-lactone 0.16 Class I No safety concern at the
estimated level of intake




104-50-7 Octano-1,4-lactone 0.12 Class I No safety concern at the
estimated level of intake




542-28-9 Pentano-1,5-lactone 0.03 Class I No safety concern at the
estimated level of intake






















O 0.004 Class II No safety concern at the
estimated level of intake
based on the MSDI
approach
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4179-38-8 2-Octylfuran 0.80 Class II Evaluated in FGE.13Rev2,
additional genotoxicity
data are required
CASrn: Chemical Abstracts Service Registry Number; MSDI: Maximised Survey-derived Daily Intake; CoE: Council of Europe; FGE: Flavouring Group Evaluation.
(a): CAS no 4313-03-5 in Union list refers to (E,E)-isomer.
(b): The unsaturated acid component identified in Grill concentrate is the (E)-isomer whereas the Union list substance is the mixture.
(c): Structural alert related to genotoxicity (a-b unsaturated carbonyl) identified via OECD QSAR Toolbox (version 4.2).
(d): Structural alert related to genotoxicity (simple aldehyde) identified via OECD QSAR Toolbox (version 4.2).
(e): Peaks could not be separated in all chromatograms.
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Table A.2: Summary of 77 constituents identified in ‘Grill flavour concentrate (vegetable)’ which have not been evaluated as flavouring substances by
EFSA























2765-11-9 Pentadecanal 0.24 Structural alert related to genotoxicity
(simple aldehyde) identified via OECD
QSAR Toolbox (version 4.2)
591-78-6 2-Hexanone O 0.004
589-63-9 Octan-4-one 0.02
2216-87-7 Undecan-3-one 0.08
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CAS no Chemical name Structural formula Relative peak area % Structural alert for genotoxicity
1534-27-6 Dodecan-3-one 0.06
540-08-9 9-Heptadecanone 0.14
– 6,7-Dodecadione – 0.01
5009-32-5 8-Nonen-2-one 0.13
62485-94-3 2-Undecen-4-one 0.45 (3-Nonyl-cyclohexene + 2-Undece-4-
one)(a)
Structural alert related to genotoxicity
(a-b unsaturated carbonyl) identified
via OECD QSAR Toolbox (version 4.2)
638-53-9 Tridecanoic acid 0.22
1002-84-2 Pentadecanoic acid 0.07
5204-64-8 (E)-3-Pentenoic acid 0.10
35194-36-6 (Z)-4-Hexenoic acid 0.06
1577-22-6 5-Hexenoic acid 1.43
1119-60-4 6-Heptenoic acid 3.48
18719-24-9 7-Octenoic acid 1.88
18654-81-4 (Z)-4-Octenoic acid 0.16
5169-51-7 (Z)-3-Octenoic acid 0.05
31642-67-8 8-Nonenoic acid 1.31
31502-23-5 (Z)-6-Nonenoic acid 0.21
57602-94-5 (E)-4-Decenoic acid 0.33
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CAS no Chemical name Structural formula Relative peak area % Structural alert for genotoxicity
2553-17-5 9-Oxo-Nonanoic acid 0.42 Structural alert related to genotoxicity
(simple aldehyde) identified via OECD
QSAR Toolbox (version 4.2)
5578-80-3 10-Oxodecanoic acid 0.20 Structural alert related to genotoxicity
(simple aldehyde) identified via OECD
QSAR Toolbox (version 4.2)
43211-62-7 Prop-2-enyl hexadecanoate 0.21
6289-31-2 Prop-2-enyl octadecanoate 0.03








4441-63-8 Cyclohexanebutyric acid 0.07
15232-87-8 1-Octyl-cyclohexene 0.47
15232-88-9 1-Nonyl-cyclohexene 0.09
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1821-12-1 4-Phenylbutyric acid 0.09
2270-20-4 5-Phenylpentanoic acid 0.06
5581-75-9 6-Phenylhexanoic acid 0.09
40228-90-8 7-Phenylheptanoic acid 0.08
– 2-Pentyl-tetrahydrofuran 0.07
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CAS no Chemical name Structural formula Relative peak area % Structural alert for genotoxicity
3777-70-6 2-Hexylfuran 0.07 Alert for genotoxicity due to structural
similarity with other 2-alkylfurans (see
Table A1: 2-pentylfuran, 2-heptylfuran
and 2-octylfuran) for which additional
genotoxicity data are required




930-68-7 2-Cyclohexen-1-one 0.09 Structural alert related to genotoxicity
(a-b unsaturated carbonyl) identified
via OECD QSAR Toolbox (version 4.2)
119-64-2 1,2,3,4-Tetrahydronaphthalene 0.02
OECD: Organisation for Economic Co-operation and Development; QSAR: quantitative structure–activity relationship.
(a): Peaks could not be separated in all chromatograms.
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Table A.3: Summary of 88 constituents tentatively identified in ‘Grill flavour concentrate
(vegetable)’ based on fragmentation pattern of homologous compounds





































Tetradecene isomer 0.5741 (Tetradecene + Tridecadiene)(a)
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3-Nonyl-cyclohexene 0.4451 (3-Nonyl-1-cyclohexene + 2-Undecene-4-one)(a)
Hexadecadiene isomer 0.472
Heptadecene isomer 0.106

















Eicosadiene isomer 0.1441 (Eicosadiene + m-Cresol)(a)
2-Nonyl-2-cyclopenten-1-one 0.153






Undecylenic acid isomer 0.812
Undecylenic acid isomer 0.599
Dodecenoic acid isomer 0.280
Dodecenoic acid isomer 0.148
Tridecenoic acid isomer 0.207
Pentadecadiene isomer 0.032
(a): Peaks could not be separated in all chromatograms.
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Appendix B – Use levels and exposure calculations









Occurrence level from other
sources(c) (mg/kg)
Combined occurrence
level from all sources(e)
(mg/kg)
Normal Maximum Average(d) Maximum Normal Maximum
01.6 Cheese and analogues 40 1 5 0 0 1 5
08.2 Processed meat, poultry and game products
in whole pieces or cuts
100 3 10 0 0 3 10
08.3 Processed comminute meat, poultry and
game products
100 4 10 0 0 4 10
09.2 Processed fish and fish products, including
molluscs, crustaceans and echinoderms
100 3 8 0 0 3 8
12.2 Herbs, spices, seasonings and condiments
(e.g. seasoning for instant noodles)
1 10 100 0 0 10 100
12.6 Sauces and like products 30 3 10 0 0 3 10
15.1 Snacks, potato-, cereal-, flour- or starch-
based (from roots and tubers, pulses and
legumes)
30 2 5 0 0 2 5
15.2 Processed nuts, including coated nuts and
nut mixtures (with e.g. dried fruit)
30 2 5 0 0 2 5
15.3 Snacks – fish based 30 2 5 0 0 2 5
(a): Most of the categories reported are the subcategories of Codex GSFA (General Standard for Food Additives) used by the JECFA in the SPET technique (JECFA, 2008). In the case of category
13.2 (complementary foods for infants and young children), further refined categories have been created so that a specific assessment of dietary exposure can be performed in young
children.
(b): For adults. In case of foods marketed as powder or as concentrates, occurrence levels must be reported for the reconstituted product, considering the instructions reported on the product
label or one of the standard dilution factors established by the JECFA (FAO/WHO 2008):
– 1/25 for powder used to prepare water-based drinks such as coffee, containing no additional ingredients,
– 1/10 for powder used to prepare water-based drinks containing additional ingredients such as sugars (ice tea, squashes, etc.),
– 1/7 for powder used to prepare milk, soups and puddings,
– 1/3 for condensed milk.
(c): As natural constituent and/or developed during the processing and/or as carry-over resulting from their use in animal feed.
(d): In order to estimate normal values in each category, only foods and beverages in which the substance is present in significant amount will be considered (e.g. for the category ‘Fresh fruit’
04.1.1., the normal concentration will be the median concentration observed in all kinds of fruit where the flavouring substance is known to occur).
(e): As added flavouring or from other sources. The normal and maximum combined occurrence levels of the substance will be assessed by the applicant either by adding up occurrence levels from
added use to that from other sources or by expert judgment based on the likelihood of their concomitant presence. This will be done both for normal use levels and for maximum use levels.
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Calculation of the dietary exposure – APET
Chronic dietary exposure – ‘Added Portions Exposure Technique’ (APET)6
The chronic APET calculations are based on the normal combined occurrence level by adding the
highest contributing portion of food and highest contributing portion of beverages (either among soft
drinks or alcoholic beverages) (see Table 4). The APET calculation for children is performed by adding
the highest contributing portion of food and the highest contributing portion of beverages (among soft
drinks). Furthermore, in the APET calculation for children the portion sizes listed in Table B.1 are
adjusted by a factor 0.63 to take into account the smaller portion sizes consumed by the child.
Adults (‘Added Portions Exposure Technique’ (APET))
On the basis of normal occurrence level from added flavouring
Solid Food: The maximum intake will be from category 8.3 (Processed comminute meat, poultry
and game products) with the normal combined occurrence level of 0.4 mg/adult per day.
Beverage: the flavouring is not used in beverages.
The total APET will be 0.4 mg/adult per day corresponding to 0.0067 mg/kg bw per day for a 60-kg
person.
Children (3-year-old child of 15-kg body weight)
Solid Food: The maximum intake will be from category 8.3 (Processed comminute meat, poultry and
game products) with the normal combined occurrence level of 0.4 9 0.63 = 0.252 mg/child per day.
Beverage: the flavouring is not used in beverages.
The total APETwill be 0.252 mg/child per day corresponding to 0.0168 mg/kg bw per day for a 15-kg
child.
Conclusion
The higher of the two values among adults and children, expressed per kg/bw per day, should be used
as the basis for the safety evaluation of the candidate substance, i.e. the value of 0.0168 mg/kg bw per
day for a 15-kg child should be compared to the appropriate NOAEL for the candidate substance.
Infants and young children
The estimate to infant exposure is currently under revision in the DATA Unit of EFSA.
Acute dietary exposure
The calculation was based on the maximum use levels and large portion size, i.e. three times standard
portion size (see Table 5). Although the substance is not intended to be used in food categories
specifically intended for infants and toddlers, these could still be exposed through consumption of foods
from the general food categories, which may contain the substance. However, at present there is no
generally accepted methodology to estimate exposure in these age groups resulting from consumption of
foods from the general categories. The APET calculation for children the portion sizes listed in Table B.1 is
adjusted by a factor 0.63 to take into account the smaller portion sizes consumed by the child.
Adults
The highest contribution comes from 3 portions of category 8.3 (Processed comminute meat,
poultry and game products) and is (3 9 100 g) 9 10 mg/kg = 3 mg/adult per day.
Children7
The highest contribution comes from 3 portions of category 8.3 (Processed comminute meat,
poultry and game products) and is (3 9 100 g) 9 0.63 9 10 mg/kg = 1.89 mg/child per day.
Infants and young children (0–1 year)
Acute dietary exposure is not calculated for infants and young children.
6 The APET has been calculated based on the occurrence levels in the food subcategories reported in the above table, with the
exclusion of categories 13.2 (complementary foods for infants and young children).
7 Based on the same considerations as for adults but using the special factors used for chronic exposure to infants.
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Appendix C – Toxicological data
Table C.1: In vitro genotoxicity data on ‘Grill flavour concentrate (vegetable)’ as such. Genotoxicity studies for individual components have been





















50–5,000 lg/plate(a) Negative Silesia Gerhard Hanke
GmbH & Co. KG (2013)
Reliable without restrictions. Study performed
under GLP and in accordance with OECD TG 471.
Two experiments were performed – the plate





0.05–0.4 lL/mL(a) Negative Silesia Gerhard Hanke
GmbH & Co. KG (2014)
Reliable without restrictions. Study performed
under GLP and in accordance with OECD TG 487
FL-No: FLAVIS number; FGE: Flavouring Group Evaluation; GLP: Good Laboratory Practice; OECD: Organisation for Economic Co-operation and Development.
(a): With and without metabolic activation.




















Wistar Han rats; M + F
3 + 3/4
Diet 0, 2.4, 12
and 60*
28 NA vivo Science
GmbH (2015)
Dose-range finding study, not performed under GLP
Wistar Han rats
10 M + 10 F
Diet 0, 2.9, 14.4
and 72**
92 11.1 vivo Science
GmbH (2016)
Study performed under GLP and in accordance with OECD TG 408
Wistar Han rats; M + F
10 M + 10 F
Diet 0, 350 14 NA Covance
(2018)
Dose-range finding study performed under GLP
Wistar Han rats; M + F
27 M + 27 F




Study performed under GLP and in accordance with OECD TG 407
A substance-related increase in hyaline droplets was observed in the
kidneys of male rats, associated with a2-globulin hyaline droplet
nephropathy specific for adult male rats and not relevant for human
risk assessment
FL-No: FLAVIS number; GLP: Good Laboratory Practice; BMDL05: benchmark dose for a 5% effect; bw: body weight; OECD: Organisation for Economic Co-operation and Development; M: male;
F: female.
*: Estimated doses based on a food consumption of 90 g/day. The actual doses were approximately 46.8, 9.4, 1.9 mg/kg bw per day for females and 42, 8.4, 1.7 mg/kg bw per day for males.
**: The mean actual food consumption over 92 days were, respectively, 73.4, 14.5, 2.9 mg/kg bw per day for females and 71.0, 14.1, 3.0 mg/kg bw per day for males.
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Appendix D – Methodology
The definition of ‘other flavouring’, referred to in Article 3(2)(h) of Regulation (EC) No 1334/20081
is ‘a flavouring added or intended to be added to food in order to impart odour and/or taste and which
does not fall under the definitions of Article 3(2)(b) – (g) of Regulation (EC) No 1334/2008’, and the
data requirements for its safety evaluation can be found in the EFSA scientific opinion: ‘Guidance on
the data required for the risk assessment of flavourings to be used in or on foods’ (EFSA CEF Panel,
2010), Part B. IV. ‘Information to be supplied with an application for the authorisation of Other
Flavourings’.
It is difficult to anticipate what kind of materials will undergo an evaluation as ‘Other Flavourings’,
which suggests that the standard evaluation template is flexible. (. . .) As a general approach, the
following data should be provided:
• full description of the production process, with emphasis on the parameters that might
influence the composition of the flavouring;
• identification and quantification of the substances present in the flavouring;
• specifications of the flavouring;
• exposure and toxicological data required to perform a risk assessment of the flavouring.
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Appendix E – Benchmark dose modelling: report
Data Description
The endpoints to be analysed are: globulin, albumin and globulin ratio (A/G) and total proteins.
Data used for the analysis:
act_dose Globulin AG ratio Total protein Gender
0.0 31.8 1.2 70 F
0.0 33.4 1.2 74 F
0.0 31.2 1.2 70 F
0.0 33.2 1.1 70 F
0.0 33.8 1.2 76 F
0.0 31.2 1.2 68 F
0.0 32.2 1.4 76 F
0.0 30.6 1.2 68 F
0.0 33.6 1.3 76 F
0.0 32.0 1.3 72 F
2.9 36.8 1.2 82 F
2.9 34.4 1.2 74 F
2.9 38.0 1.2 84 F
2.9 38.4 1.0 78 F
2.9 35.4 1.3 80 F
2.9 34.6 1.3 80 F
2.9 34.4 1.2 74 F
2.9 37.6 1.1 80 F
2.9 35.6 1.0 72 F
2.9 31.2 1.2 68 F
14.9 34.6 1.2 76 F
14.9 36.4 1.2 80 F
14.9 36.0 1.2 78 F
14.9 31.4 1.2 70 F
14.9 34.6 1.1 74 F
14.9 36.6 1.1 76 F
14.9 38.0 1.2 84 F
14.9 33.6 1.3 76 F
14.9 32.6 1.1 70 F
73.4 43.4 1.0 86 F
73.4 46.4 0.9 90 F
73.4 46.4 0.9 88 F
73.4 43.2 1.0 86 F
73.4 44.8 1.0 88 F
73.4 46.4 0.9 90 F
73.4 40.2 0.9 78 F
73.4 30.8 0.9 60 F
73.4 41.0 0.9 78 F
73.4 39.6 0.9 76 F
0.0 36.0 0.9 70 M
0.0 38.2 0.9 74 M
0.0 32.2 1.0 66 M
0.0 37.0 0.9 72 M
0.0 34.6 1.0 68 M
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act_dose Globulin AG ratio Total protein Gender
0.0 38.2 0.9 74 M
0.0 34.2 1.0 68 M
0.0 36.6 0.9 70 M
0.0 34.6 1.0 68 M
0.0 36.8 1.0 74 M
3.0 37.2 1.0 74 M
3.0 37.0 0.9 72 M
3.0 35.2 1.0 70 M
3.0 36.4 1.0 72 M
3.0 38.6 0.9 74 M
3.0 35.6 1.0 70 M
3.0 37.8 1.0 74 M
3.0 35.6 1.0 72 M
3.0 36.6 0.9 70 M
3.0 38.4 0.9 72 M
14.1 36.4 0.9 70 M
14.1 34.8 1.0 68 M
14.1 36.8 1.0 72 M
14.1 38.2 0.9 72 M
14.1 33.8 1.0 66 M
14.1 38.2 0.9 74 M
14.1 35.8 1.0 70 M
14.1 37.8 0.9 72 M
14.1 37.4 0.9 72 M
14.1 35.8 0.9 68 M
71.0 50.6 0.8 90 M
71.0 49.8 0.8 90 M
71.0 47.0 0.8 86 M
71.0 47.4 0.8 86 M
71.0 46.2 0.9 86 M
71.0 46.2 0.8 84 M
71.0 45.6 0.8 82 M
71.0 42.6 0.8 78 M
71.0 46.8 0.8 82 M
71.0 49.4 0.7 86 M
Response variable: Globulin
The following outliers were identified for Expon. m3-abv:
act_dose Gender Globulin AGratio Totalprotein
72 F 30.8 0.9 60
The following outliers were identified for Hill m3-abv:
act_dose Gender Globulin AGratio Totalprotein
72 F 30.8 0.9 60
Flavouring Group Evaluation 501
www.efsa.europa.eu/efsajournal 45 EFSA Journal 2019;17(5):5675
The following outliers were identified for Inv.Expon. m3-abv:
act_dose Gender Globulin AGratio Totalprotein
72 F 30.8 0.9 60
The following outliers were identified for LN m3-abv:
act_dose Gender Globulin AGratio Totalprotein
72 F 30.8 0.9 60
Response variable: Totalprotein
The following outliers were identified for Expon. m3-abv:
act_dose Gender Globulin AGratio Totalprotein
72 F 30.8 0.9 60
The following outliers were identified for Hill m3-abv:
act_dose Gender Globulin AGratio Totalprotein
72 F 30.8 0.9 60
The following outliers were identified for Inv.Expon. m3-abv:
Dose Gender Globulin AGratio Totalprotein
72 F 30.8 0.9 60
The following outliers were identified for LN m3-abv:
Dose Gender Globulin AGratio Totalprotein
72 F 30.8 0.9 60
Selection of the BMR
The benchmark response (BMR) used is a 5% change in mean response compared to the controls.
The benchmark dose (BMD) is the dose corresponding with the BMR of interest.
A 90% confidence interval around the BMD will be estimated, the lower bound is reported by BMDL
and the upper bound by BMDU.
Software used
Results are obtained using the EFSA web-tool for BMD analysis, which uses the R-package PROAST,
version 66.24, for the underlying calculations.
Specification of Deviations from Default Assumptions
None.
Dose-response models
Default set of fitted models:
Model Number of parameters Formula
Null 1 y = a
Full No. of groups y = group mean
Exp model 3 3 y = a  exp(bxd)
Exp model 4 4 y = a  (c  (c  1) exp(bxd))
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Model Number of parameters Formula
Hill model 3 3
y ¼ a  1 xd
bd þ xd
 
Hill model 4 4
y ¼ a  1 (c-1)xd
bd þ xd
 
Inverse exponential 4 y = a  (1 + (c  1)exp(bxd))
Log-normal Family 4 y = a  (1 + (c  1)/(lnb + dlnx))
As a covariate is included in the analysis, these models will also be fitted assuming that some of the
parameters (background response parameter (a), potency parameter (BMD) and/or variance (var))
depend on the subgroup defined by the covariate. Therefore, the number of parameters in each model
might be larger than indicated in the table above.
Procedure for selection of BMDL
Flow chart for selection of BMDL:
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model converged loglik npar AIC
full model yes 109.87 9 201.74
full-v yes 115.55 10 211.10
null modelv yes 51.17 3 96.34
null model-a-v yes 54.71 4 101.42
Expon. m3-v yes 98.98 5 187.96
Expon. m3-av yes 109.22 6 206.44
Expon. m3-abv yes 110.42 7 206.84
Expon. m5-av yes 109.22 7 204.44
Expon. m5-abv yes 110.42 8 204.84
Hill m3-av yes 109.22 6 206.44
Hill m3-abv yes 110.42 7 206.84
Hill m5-av yes 109.22 7 204.44
Hill m5-abv yes 110.42 8 204.84
Inv.Expon. m3-av yes 109.17 6 206.34
Inv.Expon. m3-abv yes 110.35 7 206.70
Inv.Expon. m5-av yes 109.16 7 204.32
Inv.Expon. m5-abv yes 110.34 8 204.68
LN m3-av yes 109.18 6 206.36
LN m3-abv yes 110.37 7 206.74
LN m5-av yes 109.18 7 204.36
LN m5-abv yes 110.36 8 204.72
OF NOTE: the AIC of the best model (minimum AIC) is more than two units larger than that of the
full model. However, considering that the fitted models are quite close to the full model, the results
can be still considered acceptable.
Estimated Model Parameters
EXP
estimate for var-F : 0.006715
estimate for var-M : 0.001934
estimate for a-F : 34.05
estimate for a-M : 36.2
estimate for CED-F : 33.82
estimate for CED-M : 28.96
estimate for d- : 1.882
HILL
estimate for var-F : 0.006715
estimate for var-M : 0.001934
estimate for a-F : 34.05
estimate for a-M : 36.2
estimate for CED-F : 33.83
estimate for CED-M : 28.95
estimate for d- : 1.884
INVEXP
estimate for var-F : 0.006751
estimate for var-M : 0.001932
estimate for a-F : 34.1
estimate for a-M : 36.25
Flavouring Group Evaluation 501
www.efsa.europa.eu/efsajournal 48 EFSA Journal 2019;17(5):5675
estimate for CED-F : 33.59
estimate for CED-M : 29.19
estimate for d- : 0.3172
LOGN
estimate for var-F : 0.006741
estimate for var-M : 0.001933
estimate for a-F : 34.09
estimate for a-M : 36.24
estimate for CED-F : 33.88
estimate for CED-M : 29.74
estimate for d- : 0.6196
The following outliers were identified:
model act_dose Gender Globulin AGratio Totalprotein
Expon. m3-abv 72 F 30.8 0.9 60
Hill m3-abv 72 F 30.8 0.9 60
Inv.Expon. m3-abv 72 F 30.8 0.9 60
LN m3-abv 72 F 30.8 0.9 60
Weights for Model Averaging
EXP HILL INVEXP LOGN
0.26 0.26 0.24 0.24
Final BMD Values
endpoint subgroup BMDL BMDU
Globulin F 22.0 55.0
Globulin M 18.1 51.7
Confidence intervals for the BMD are based on 200 bootstrap data sets.
Visualisation
Plot for response ‘Globulin’.
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Response variable: AGratio
Fitted Models
model converged loglik npar AIC
full model yes 110.94 9 203.88
full-v yes 111.78 10 203.56
null model yes 37.00 2 70.00
null model-a yes 61.53 3 117.06
Expon. m3- yes 54.65 4 101.30
Expon. m3-a yes 106.34 5 202.68
Expon. m3-ab yes 109.11 6 206.22
Expon. m5-a yes 106.34 6 200.68
Expon. m5-ab yes 109.11 7 204.22
Hill m3-a yes 106.34 5 202.68
Hill m3-ab yes 109.11 6 206.22
Hill m5-a yes 106.34 6 200.68
Hill m5-ab yes 109.10 7 204.20
Inv.Expon. m3-a yes 106.28 5 202.56
Inv.Expon. m3-ab yes 109.01 6 206.02
Inv.Expon. m5-a yes 106.27 6 200.54
Inv.Expon. m5-ab yes 109.00 7 204.00
LN m3-a yes 106.30 5 202.60
LN m3-ab yes 109.05 6 206.10
LN m5-a yes 106.29 6 200.58
LN m5-ab yes 109.04 7 204.08
Estimated Model Parameters
EXP
estimate for var- : 0.003699
estimate for a-F : 1.2
estimate for a-M : 0.9544
estimate for CED-F : 24.61
estimate for CED-M : 30.47
estimate for d- : 1.473
HILL
estimate for var- : 0.003699
estimate for a-F : 1.2
estimate for a-M : 0.9544
estimate for CED-F : 24.61
estimate for CED-M : 30.47
estimate for d- : 1.475
INVEXP
estimate for var- : 0.003706
estimate for a-F : 1.198
estimate for a-M : 0.953
estimate for CED-F : 23.35
estimate for CED-M : 31.04
estimate for d- : 0.2428
LOGN
estimate for var- : 0.003703
estimate for a-F : 1.199
estimate for a-M : 0.9536
estimate for CED-F : 23.58
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estimate for CED-M : 30.85
estimate for d- : 0.4686
Weights for Model Averaging
EXP HILL INVEXP LOGN
0.26 0.26 0.24 0.24
Final BMD Values
endpoint subgroup BMDL BMDU
AGratio F 12.8 51.5
AGratio M 18.4 56.6
Confidence intervals for the BMD are based on 200 bootstrap data sets.
Visualisation
Plot for response ‘AGratio’.
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Response variable: Total proteins
Fitted Models
model converged loglik npar AIC
full model yes 111.68 9 205.36
full-v yes 122.63 10 225.26
null modelv yes 79.41 3 152.82
null model-a-v yes 80.66 4 153.32
Expon. m3-v yes 113.08 5 216.16
Expon. m3-av yes 114.97 6 217.94
Expon. m3-bv yes 113.97 6 215.94
Expon. m3-abv yes 119.11 7 224.22
Expon. m5-v yes 113.08 6 214.16
Expon. m5-av yes 114.97 7 215.94
Expon. m5-bv no 113.97 7 213.94
Expon. m5-abv yes 119.11 8 222.22
Hill m3-v yes 113.08 5 216.16
Hill m3-av yes 114.97 6 217.94
Hill m3-bv yes 113.97 6 215.94
Hill m3-abv yes 119.11 7 224.22
Hill m5-v no 113.08 6 214.16
Hill m5-av no 114.97 7 215.94
Hill m5-bv yes 113.97 7 213.94
Hill m5-abv yes 119.11 8 222.22
Inv.Expon. m3-v yes 113.09 5 216.18
Inv.Expon. m3-av yes 114.98 6 217.96
Inv.Expon. m3-bv yes 113.99 6 215.98
Inv.Expon. m3-abv yes 119.12 7 224.24
Inv.Expon. m5-v yes 113.09 6 214.18
Inv.Expon. m5-av yes 114.98 7 215.96
Inv.Expon. m5-bv yes 113.99 7 213.98
Inv.Expon. m5-abv yes 119.12 8 222.24
LN m3-v yes 113.09 5 216.18
LN m3-av yes 114.98 6 217.96
LN m3-bv yes 113.99 6 215.98
LN m3-abv yes 119.12 7 224.24
LN m5-v yes 113.09 6 214.18
LN m5-av yes 114.98 7 215.96
LN m5-bv yes 113.99 7 213.98
LN m5-abv yes 119.12 8 222.24
Estimated Model Parameters
EXP
estimate for var-F : 0.00643
estimate for var-M : 0.001307
estimate for a-F : 74.89
estimate for a-M : 70.89
estimate for CED-F : 64.04
estimate for CED-M : 51.16
estimate for d- : 4
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HILL
estimate for var-F : 0.00643
estimate for var-M : 0.001307
estimate for a-F : 74.89
estimate for a-M : 70.89
estimate for CED-F : 64.03
estimate for CED-M : 51.14
estimate for d- : 4
INVEXP
estimate for var-F : 0.006431
estimate for var-M : 0.001306
estimate for a-F : 74.89
estimate for a-M : 70.89
estimate for CED-F : 65.45
estimate for CED-M : 56.38
estimate for d- : 0.8822
LOGN
estimate for var-F : 0.006431
estimate for var-M : 0.001306
estimate for a-F : 74.89
estimate for a-M : 70.89
estimate for CED-F : 66.79
estimate for CED-M : 59.71
estimate for d- : 2.235
The following outliers were identified:
model act_dose Gender Globulin AGratio Totalprotein
Expon. m3-abv 72 F 30.8 0.9 60
Hill m3-abv 72 F 30.8 0.9 60
Inv.Expon. m3-abv 72 F 30.8 0.9 60
LN m3-abv 72 F 30.8 0.9 60
Weights for Model Averaging
EXP HILL INVEXP LOGN
0.25 0.25 0.25 0.25
Final BMD Values
endpoint subgroup BMDL BMDU
Totalprotein F 42.3 76.7
Totalprotein M 25.9 56.2
Confidence intervals for the BMD are based on 200 bootstrap data sets.
Visualisation
Plot for response ‘Total proteins’.
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Appendix F – Schematic representation of the production process of Grill
flavour concentrate (vegetable) (confidential)
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